[VIRTUAL] FIRST IN HUMAN STUDY WITH ALZ-101, A UNIQUE AND HIGHLY SPECIFIC THERAPEUTIC VACCINE AGAINST THE NEUROTOXIC OLIGOMERIC FORM OF Aβ 1-42

ALZ-101 - Alzinova

A. Sandberg1; I. Nylander1; M. Sheinin2,3; J. Rinne2,4,5; Z. Lovro2; K. Torfgård1; A. Bylock1

Aug 10, 2020